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Preamble
The diagnosis of patients with acute chest pain
remains a challenging problem. There are approx-
imately 6 million chest pain related emergency
department (ED) visits annually in the US alone
[1]. Approximately 5.3% of all ED patients are
seen because of chest pain and reported admission
rates are between 30% and 72% for these patients
[2].
Only 15–25% of patients presenting with acute chest
pain are ultimately diagnosed as having an acute
coronary syndrome (ACS). Of those patients who were
admitted to the chest pain unit, 44% ultimately had
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significant pathology ruled-out in one series [3]. The
cost of chest pain triage and management has been
estimated to be as high as $8 billion dollars annually
with most of those patients ultimately not having ACS
[4]. Moreover, 2–8% of patients are discharged from the
ED and later diagnosed as having ACS [5–8]. The
mortality rate for these patients is approximately 25%,
which is twice as high as those who are admitted [7].
Malpractice litigation over missed myocardial infarc-
tion (MI) represents the largest proportion of ED
lawsuits in the U.S. [9]. There is thus great desire to
find new tests to safely and expeditiously discharge low
risk patients.
Recent technical advances in cardiovascular CT
angiography (CCTA) have shown great promise for
improving our diagnostic capabilities through non-
invasive imaging. There are several articles showing
excellent accuracy for diagnosing coronary heart
disease with the latest 64-slice multi-detector CT
(MDCT) scanner [10–12]. Newer technology has
arrived with dual-source 64-slice MDCT [13] and the
imminent introduction of 256-slice MDCT that are
expected to further improve on this diagnostic
accuracy. Scanners that can perform cardiovascular
CT are becoming more widely available. As has been
the case for many rapid developments in medicine, in
concert with this diffusion of technology there is the
risk of application for clinical patient care without the
scientific, rigorous study required. The concept of
evaluating patients with acute chest pain with ECG-
gated CT in the ED is but one such example, where,
based on rapidly evolving technology, tests are being
pushed to clinical application faster than our ability to
scientifically evaluate their benefit. This is in part
driven by industry, which wishes to sell more
scanners, pioneering entrepreneurs, and by the ED
in the setting of acute chest pain, which increasingly
relies on imaging to enable faster risk stratification of
patients and thereby minimize patient stay and costs.
While there is a consensus that CT may indeed
improve disposition of patients with acute chest pain,
at this point, there is little data demonstrating typical
coronary CT findings in patients with and without
ACS among patients with chest pain. Thus, there is
the potential of inappropriate use of new technology
leading to additional testing rather than saving
admissions or cost. Data from observational trials
are needed to demonstrate the safety and feasibility of
CT in the setting of acute chest pain, to identify the
target population in whom admissions could be
reduced, the relation of CT findings on plaque and
stenosis to MI and unstable angina pectoris. Eventu-
ally randomized diagnostic trials are essential to
prove the incremental value of cardiac CT to current
standard of care, including stress testing similar to the
evaluation of SPECT a decade ago [14].
Currently there are no guidelines that have been
published for the use of CT for acute chest pain.
Appropriateness criteria have recently been published
[15]. More general guidelines are currently under
development. However, because of the great interest
and pressure from a variety of groups to utilize this
technology, there is value in providing interim guid-
ance. For this reason, the North American Society for
Cardiac Imaging (NASCI) and the European Society of
Cardiac Radiology (ESCR) assembled a group of
expert radiologists, cardiologists and emergency phy-
sicians representing the collective experience from the
United States, Canada and Europe to review the
literature, indicate areas in need for more research
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and provide a basis in the future for the development of
comprehensive guidelines.
Co-endorsed White Papers and guidelines by var-
ious societies have been written before on various
topics. We believe however that this is the first attempt
to bring together the different experiences from
different countries and continents whose medical
systems are significantly different. We believe that
this combined experience has the advantage that
underlying biases from local practice becomes less
relevant and that the underlying fundamental truths
become relatively more important. The ESCR and
NASCI are planning to work together in the future to
bring together experts to discuss available evidence, to
provide guidance to the practitioner and to further
advance the field of cardiovascular imaging and
provide a basis for practice with evolving technologies.
How to manage chest pain: the emergency
department perspective
In the emergency department setting, the symptoms
and clinical signs of patients with chest pain are
variable but it is important to distinguish life
threatening causes that need rapid or immediate
intervention from those that are less likely to be fatal
but still need in-patient treatment and those that can
be managed supportively on an out-patient basis
(Table 1) [16].
Acute Coronary Syndrome
In the United States more than 335,000 people die of
heart disease in an ED or before reaching a hospital
every year. Of patients who die suddenly because of
coronary heart disease, 50% of men and 64% of
women have no previous symptoms. When a patient
presents with chest pain, they are typically risk
stratified with an appropriate history and physical,
and electrocardiogram (ECG), chest X-ray and
laboratory studies including cardiac biomarkers.
Obtaining a timely ECG is important to identify the
small subset of patients with an ST Elevation
Myocardial Infarction (STEMI) who will benefit
from a coronary intervention (PCI or thrombolysis)
The majority of patients without a STEMI are further
risk stratified into one of three categories: (1) high
risk for acute coronary syndrome (ACS) or Non ST
Elevation MI (NSTEMI), (2) low risk for ACS, or (3)
noncardiac chest pain. A number of clinical decision
rules tools are available to risk stratify patients into
one of the above three categories, but none have a
high sensitivity and specificity with some no better
than clinical impression.
One risk stratification tool that is widely used in
emergency departments is the Thrombosis in
Myocardial Infarction (TIMI) risk score that predicts
the triple endpoint of death, new or recurrent
myocardial infarction, or need for urgent target vessel
revascularization within 2 weeks of presentation
(Table 2) [17].
Table 1 Common potential causes of non-traumatic chest pain
Life threatening Non-life threatening
Acute Coronary
Syndrome
Pneumonia/Pulmonary Parenchymal
Disease
Pulmonary Embolism Pulmonary, Mediastinal, or Pleural
Neoplasm
Aortic Dissection Musculoskeletal Injury or
Inflammation
Intramural Hematoma Cholecystitis
Penetrating Aortic
Ulcer
Pancreatitis
Aortic Aneurysm/
Rupture
Herpes Zoster
Esophageal Rupture Hiatus Hernia/GERD/Esophageal
Spasm
Pericardial Tamponade Pericarditis/Myocarditis
Tension
Pneumothorax
Simple Pneumothorax
Table 2 TIMI risk score for Unstable Angina and NSTEMI
• Age 65 years
• History of known CAD (documented prior coronary artery
stenosis >50%)
• 3 conventional cardiac risk factors (age, male sex, family
history, hyperlipidemia, diabetes mellitus, smoking, obesity)
• Use of aspirin in the past 7 days
• ST-segment deviation (persistent depression or transient
elevation)
• Increased cardiac biomarkers (troponins)
• 2 anginal events in the preceding 24 h
T I M I = T h r o m b o s i s i n M y o c a r d i a l I n f a r c t i o n ;
CAD = coronary artery disease
Score = sum of number of above characteristics
T I M I = T h r o m b o s i s i n M y o c a r d i a l I n f a r c t i o n ;
CAD = coronary artery disease
Score = sum of number of above characteristics
Int J Cardiovasc Imaging (2007) 23:415–427 417
123
The low risk group is defined by a score of 0 or 1
and a <5% likelihood of requiring intervention. The
high risk group is defined by a score of 6 or 7 and a
40% likelihood of requiring intervention. This
approach has been validated in a number of addi-
tional trials [18–20].
A computerized system for risk assessment is in
use in some emergency departments to aid in
diagnosis [21]. A risk score for patients with normal
troponin concentrations has recently been proposed
[22, 23]. Specific recommendations for an early
invasive strategy in patients with NSTEMI include
any of the following high-risk indicators: [24]
• Recurrent angina/ischemia at rest or with low-
level activities despite intensive anti-ischemic
therapy.
• Elevated cardiac specific biomarkers, TnT or Tnl.
• New or presumably new ST-segment depression.
• Recurrent angina/ischemia with congestive heart
failure symptoms, an S3 gallop, pulmonary
edema, worsening raˆles, new or worsening mitral
valve regurgitation.
• High-risk findings on noninvasive stress testing.
• Depressed left ventricular systolic function (e.g.,
ejection fraction <40% on noninvasive study).
• Hemodynamic instability
• Sustained ventricular tachycardia.
• Percutaneous Coronary Intervention (PCI) within
6 months.
• Prior CABG.
Treatment and disposition is based on the level of risk
assigned to the patient. Patients with a NSTEMI or
who are deemed at high risk for ACS are typically
admitted to the hospital. Patients with non-cardiac
and non-life threatening chest pain are typically
discharged home with outpatient follow-up. Low risk
ACS patients usually present a quandary. These
patients usually require a period of observation with
serial enzymes and then a determination is made
whether provocative stress testing is required. In
some facilities, observation units tailored toward the
evaluation of chest pain have made prolonged
evaluations in the emergency department possible.
Patients receive serial biomarkers, observation in a
telemetry setting, and most receive some form of
cardiac stress testing. Cardiac stress testing ranges
from simple treadmill tests to the newer cardiac PET
scans. None of these tests is perfect and most if not
all are not available 24 h day/7 days a week. If the
patient has rising cardiac biomarkers or has a positive
cardiac stress test, they are usually admitted for
cardiac catheterization and further management.
In spite of this aggressive approach to chest pain in
the ED, even in the population at low risk for ACS,
between 2–8% of patients are inappropriately dis-
charged and later found to have an ACS [5–8]. These
discharged patients have a significantly increased
morbidity and mortality. If it were possible to
accurately predict high risk in patients with potential
NSTEMI or, conversely, to accurately exclude ACS
during the early observation period, the number of
patients admitted for evaluation of chest pain could
be significantly reduced with a commensurate reduc-
tion in cost of care. In addition, the earlier identifi-
cation of high risk ACS patients could lead to earlier
treatment initiated in the Emergency Department
with the possibility of improved patient outcomes.
CCTA may be used in order to visualize the
coronary arteries and to determine whether there are
plaques or thrombi narrowing or occluding the vessel.
If CCTA could be performed immediately or during
the observation period for ACS at a cost that is less
than that required for outpatient monitoring, there
would be a significant saving to the health care
system. Because of medical malpractice issues in the
U.S. [25] and the high likelihood of a poor outcome if
a patient with ACS is discharged, the test must have a
high negative predictive value minimizing missed
ACS. Ideally, the true positives would all undergo
coronary artery revascularization and the number of
indeterminate cases that require further observation
would be reduced. A model Cardiac Chest Pain
Pathway that incorporates CCTA is shown in Fig. 1.
Early supporting data for the use of CCTA for acute
chest pain is now appearing in the literature [26–28].
Although this Pathway represents one possible
concept, further work is necessary to clarify the role
of stenosis and plaque assessment for risk assessment
of patients with acute chest pain. This relates both to
the concept of mild to moderate stenosis as detected
by CCTA and the necessity of stress testing or
coronary angiography (CAG) in these patients, as
well as the concept of plaque burden in CCTA as a
tool for risk stratification. Both concepts have been
recently addressed [26].
Very important for the success of cardiac CT in this
application will be our ability to exactly determine
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123
the target patient population. While the broader
population of all comers with undifferentiated chest
pain has a very low incidence of ACS, pulmonary
embolism (PE), or aortic dissection, patients with
inconclusive initial ED evaluation admitted to the
hospital to rule out MI may benefit the most as 10–15%
of those patients will develop an ACS. Besides the
detection of stenosis and plaque it may prove useful to
evaluate the additional benefit from the assessment of
global and regional LV function, which may identify
stunned myocardium.
Pulmonary Embolism
Patients who present to the ED with a suspected PE
can be risk stratified using the Wells’ clinical
decision rule (Table 3). The likelihood of a PE is
low if the score is four or less and the D-dimer is
Chest pain compatible with ischemia
History
Physical
        EKG,
Cardiac enzymes
Risk stratification
Normal or Non-specific Diagnostic of NSTEMI/UA Diagnostic of STEMI 
Non-invasive    Admission         Invasive Angiography 
Imaging
Coronary CT path Medical Rx        Revascularization 
      Results 
Normal-Mild (0-49%)   Moderate Stenosis (50-70%)      Severe Stenosis (>70%) 
    Non-Diagnostic 
   Stress Imaging  Invasive Angiography
Discharge      Admission
Fig. 1 Model Cardiac
Chest Pain Pathway that
incorporates CCTA
Table 3 Well’s Clinical Decision Rule for Pulmonary
Embolism [29]
Variable Points
• Clinical signs and symptoms of deep vein
thrombosis
3.0
• Alternative diagnosis less likely than pulmonary
embolism
3.0
• Heart rate >100/min 1.5
• Immobilization (>3days) or surgery in the previous
4 weeks
1.5
• Previous pulmonary embolism or deep vein
thrombosis
1.5
• Hemoptysis 1.0
• Malignancy (receiving treatment, treated in the last 6
mo or palliative)
1.0
Clinical probability of pulmonary embolism unlikely: 4 or less
points; clinical probability of pulmonary embolism likely:
more than 4 points
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negative. If the patient has a score greater than 4 then
further investigations are required to exclude the
diagnosis of PE. The most commonly used imaging
techniques are a nuclear ventilation/perfusion scan or
chest CT depending on institution and availability. A
negative CT study is associated with a low risk for
subsequent fatal and nonfatal venous thromboembo-
lism (VTE) [28]. Therefore, in the patient with
undifferentiated chest pain and a moderate to high
probability of PE, a CT is indicated. If the patient is
high risk for PE but has a negative CT scan, further
testing may be indicated. A normal D-dimer or a
negative evaluation of the lower extremity venous
system with a contrast CT or US makes the diagnosis
of PE unlikely. When the clinical probability is low, a
normal D-dimer test excludes the diagnosis of PE and
a CT is typically not performed.
Acute Aortic Syndromes
The clinical presentation of patients with acute aortic
syndromes typically present with ripping or tearing
chest discomfort that is sudden in onset, severe,
substernal and may radiate to arms or back. The most
common predisposing factors are hypertension,
increasing age and pregnancy, while less common
syndromes include Marfan’s syndrome and Behc¸et’s
disease. The pain may start in the epigastrium or
abdomen and radiate to the back. Hypotension,
unequal pulses, acute aortic regurgitation or sugges-
tive electrocardiographic changes may be features as
well. Aortic disease includes entities such as acute
aortic dissection, dissecting intramural hematoma,
aortic penetrating ulcer, mycotic aneurysm, and
atherosclerotic aneurysm with and without rupture.
Because these may be fatal, rapid diagnosis and
institution of therapy is desirable. MDCT is the
diagnostic test most often used to make the diagnosis
because it can distinguish among the various etiol-
ogies of the acute aortic syndrome and define the
extent of the disease process [30].
Alternative diagnoses
MDCT is capable of detecting a multitude of
alternative causes of acute chest pain. These include
hiatus hernia, pneumonia, intrathoracic mass, peri-
cardial effusion and pericarditis, esophageal mass or
rupture, pleural effusion, pancreatitis, spontaneous
fracture (spine, sternum, cough fracture of rib). Many
patients with ill-defined symptoms or uncharacteristic
presentations may be initially considered to have an
acute coronary syndrome but may have a pulmonary
embolism or another disease. Some patients have
more than one disease process causing their symp-
toms [31].
Triple Rule-Out
MDCT is currently the diagnostic test of choice for
the diagnosis of pulmonary embolism and acute
aortic syndrome. As mentioned above, alternative
diagnoses may also be found or excluded as causes of
chest pain. If MDCT were robust enough to exclude
an acute coronary syndrome in patients without ST
elevation, and sensitive enough to indicate which
patients with NSTEMI are likely to have treatable
coronary disease, it might be used to shorten the
observational period for patients with suspected ACS
to either rule-out cardiac causes for chest pain or
ensure timely institution of specific therapy.
Ultimately, we must ask: Is there a single MDCT
study that can be performed that can accurately,
expeditiously and cost-effectively diagnose coronary,
pulmonary and aortic disease in the ED, the so-called
‘‘triple rule-out?’’ The question may also be asked, is
there a clinical need for such a test? ED physicians
usually feel that it is relatively uncommon that they
are uncertain of all three diagnostic considerations,
thus, single or dual rule out may be sufficient. As of
this writing, there are no large prospective studies
where MDCT has been used for this purpose and
further research is desirable to better define the role
for triple rule-out.
CT protocol
The CT protocol used to evaluate patients who
present to the ED is an evolving and multifaceted
challenge. The development of newer generations of
MDCT that can evaluate the coronary arteries
routinely has injected an additional promising
but confounding element. As discussed above, the
challenge is to distinguish life-threatening cardiac
420 Int J Cardiovasc Imaging (2007) 23:415–427
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etiologies such as ACS from non-cardiac causes
including pulmonary embolism, and aortic dissection.
Specific protocol issues include the appropriate prep-
aration for the CT scan, whether to use calcium scoring,
contrast injection parameters, and strategies used to
acquire CTA. Ideally, these issues can be addressed in a
manner that can be generalized to different types of
advanced scanners and practice settings.
Scanner technology
Investigation of the heart and in particular the coronary
arteries requires simultaneous fast image acquisition
and high spatial resolution. The ability of CT scanners
to achieve high temporal and spatial resolution has
improved tremendously in recent years. The availabil-
ity of 64-detector-row CT (64DCT) and, even more
recently, Dual Source CT technology, has been of
particular value for cardiac CT examinations in that
isotropic half-millimeter spatial resolution and tempo-
ral resolution as fast as 83 ms is attainable. The spatial
resolution of CT is now only 2 to 3 times lower than
that of the most optimal conventional coronary
angiography (CAG), which is sufficient to visualize
small segments of the coronary artery tree down to the
third generation vessels [32].
Preparation for the CT scan
In patients with heart rates above 65 bpm, patient
preparation with beta-blockers is necessary to achieve
sufficiently low heart rates with 64-slice technology
[33]. This typically involves administration of 50–
100 mg Metoprolol 1 h prior to the CT scan, followed
by 5 to 20 mg Metoprolol intravenously to patients in
whom the heart rate is still above 65 bpm once in the
CT scanner. In patients in whom the scan must be
obtained with a heart rate of 80 bpm and above, image
reconstruction in the systolic phase of the cardiac cycle
often results in superior image quality [32]. Nitroglyc-
erin (0.5 mg sublingual) is given to dilate the coronary
arteries if the patient’s blood pressure will tolerate it.
With further improvement of technology, beta-block-
ers may no longer be indicated.
Calcium scoring
Screening for coronary calcium by CT is a fast and
simple procedure that allows determination of the
amount of calcified plaques in the coronary arteries
and estimation of the extent of the entire atheroscle-
rotic plaque burden. Screening for coronary calcium
was introduced more than a decade ago with the use
of electron beam CT (EBT). Electron beam CT is a
dedicated cardiac CT system without moving parts
and permits very short exposure times when scanning
the heart. The design of this machine made it suitable
for low dose cross sectional scanning of the heart to
detect coronary calcium.
Coronary calcium screening by EBT is performed
with 3 mm consecutive slices through the range of the
entire heart. No administration of contrast media is
required. Every scan is triggered prospectively by the
ECG signal to the mid diastole interval. Usually 40
heartbeats are necessary to acquire the entire volume
resulting in a breath-hold time of approximately 30 s.
Coronary calcium is identified as lesions in the
coronary arteries with a density of 130 HU and
above. A score value is calculated by a dedicated
algorithm, which takes the peak density and the area
of any individual lesion into account [34]. The total
score corresponds to the sum of all lesions in all three
coronary arteries, and is commonly provided in
percentile for age and gender.
Coronary calcium screening may also be per-
formed with MDCT systems. Four slices are mini-
mally required to perform coronary calcium scanning
with a MDCT. Depending on the number of slices
available, the spiral scan can be performed within 10
to 20 s [35]. To improve reproducibility of the
measurement, overlapping slice reconstruction is
recommended [36]. However, this results in a
relatively high dose of radiation so that a prospec-
tively triggered sequential imaging approach analo-
gous to EBT is commonly used. Images are
evaluated according to the procedure suggested for
coronary calcium screening with the EBT. To
improve the reproducibility and comparability of
coronary calcium screening with different CT scan-
ners an international consortium has been founded
with the aim to standardize the measurement. The
consortium proposed to use the quantification of the
absolute mass in mg calcium-hydroxyapartite rather
than assessing the calcium score. For the standard-
ized measurement frequent calibration of the CT
scanner is required with dedicated phantoms. The
foremost issue with coronary calcium screening for
patients with acute coronary syndrome is to detect
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coronary calcium with a sensitivity that is as high as
possible.
Initially, scanning for coronary calcium with EBT
was intended to screen for coronary atherosclerosis in
asymptomatic persons to determine the risk of acute
coronary events. However, in the late nineties some
authors reported the use of coronary calcium screen-
ing for patients with angina-like symptoms and
negative cardiac enzymes. Laudon et al. described
the use of CAC scanning in the emergency depart-
ment in more than 100 patients, pointing out a
negative predictive value of 100% [37]. McLaughlin
et al. reported a negative predictive value of 98% in
134 patients presenting with chest pain to the
emergency department [38]. Georgiou et al. followed
almost 200 patients with chest pain in the emergency
department and found that the presence of coronary
artery calcium in this cohort is a strong predictor for
future cardiac events and conversely patients with a
negative coronary calcium scan may safely be
discharged immediately from the ED [39]. A problem
with these studies is that the negative predictive value
is not as great in younger patients. Thus coronary
calcium may not be widely applicable in this patient
population. In addition, because of its high costs and
limited availability, EBT has never been widely used
as a stand-alone tool to triage patients with chest
pain.
Coronary artery calcium scoring by MDCT may
be useful in the ED setting prior to CTA in that the
quality of the CTA is likely to be impaired or non-
diagnostic if large quantities of coronary calcium are
found. A decision to proceed with CTA must then be
made. Moreover, the calcium score can be compared
to existing age and gender benchmarks to guide
primary prevention as an outpatient if the patient is
not admitted [40, 41]. CAC is relatively common in
this patient population even in patients with non-
cardiac causes of chest pain. Thus CTA may still be
of value to evaluate for stenoses. Clearly, there is a
need for more research to define the relative roles of
both CAC and CTA for acute chest pain patients.
Calcium screening will be addressed in more detail in
a future ESCR-NASCI Consensus Statement.
CTA protocol
More advanced MDCT technology allows not only
assessment of the calcified atherosclerotic plaque
burden but also visualization of the lumen and wall of
the coronary arteries using contrast material. In
addition, other causes of chest pain such as pulmo-
nary embolism, aortic dissection, and pneumonia can
be evaluated using CTA. Provided that optimized
images of the entire cardiac cycle are not required,
dose modulation or ECG-pulsing can be used to
reduce redundant radiation during the systolic phase
while preserving coronary artery images of good
quality [42]. Specific ED chest pain protocols in
which the differential diagnosis includes a coronary
artery etiology can be divided into two groups. If the
patient is stable and primary clinical suspicion is
angina, a dedicated cardiac CTA may be sufficient.
Alternatively, if the clinical evaluation is less specific
and differential considerations include angina and
other serious causes of acute chest pain, a compre-
hensive or global evaluation may be deemed appro-
priate. The latter protocol is also termed the triple
threat or triple rule-out protocol. Each of these
protocols is discussed in turn.
Dedicated CTA
A typical CT angiography (CTA) investigation of the
heart with most modern CT scanners usually requires
a breath hold time of 10 s or less and 60–80 ml of
contrast media. The regimen for intravenous contrast
medium administration has changed with newer
scanners. Formerly, with slower scanning the priority
was to extend the contrast bolus in order to maintain
homogenous enhancement during the entire scanning
period. Now that the scan time with 64DCT is
typically no more than 10 s for the entire heart, high
contrast enhancement must be achieved during the
comparatively short scanning period. One method is
to calculate the amount of contrast medium based on
the bodyweight of the patient; for every kilogram of
bodyweight administering 0.5 g of iodine. For a
cardiac CT study the bodyweight-adapted amount of
contrast medium is administered within 20 s. Highly
concentrated contrast media is well suited to this
approach, in order to keep the intravenous flow rate
within a reasonable order of magnitude, particularly
in obese patients. To lower the viscosity and to
improve administration the contrast medium should
be warmed to body temperature. In order to achieve
correct timing, either a test injection or automated
threshold-based bolus timing may be used. The
422 Int J Cardiovasc Imaging (2007) 23:415–427
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threshold with automated bolus timing is often set at
150 HU.
In principle it is advisable to have some contrast in
the right ventricle in order to identify the septum and
the right ventricular myocardium. However, any CTA
study should be performed in mid-inspiration in order
to avoid the ‘‘Valsalva maneuver’’. This effect
occurs during deep inspiration when an influx of
contrast medium into the right atrium is impeded
resulting in non-homogenous enhancement of the
cardiac structures. A saline flush should always be
performed immediately after the administration of
contrast medium in order to flush the veins of
remaining contrast medium and to maintain a tight
contrast bolus, while it aids in the assessment of the
right coronary artery and posterior descending artery.
The scanning range extends from the level of the
carina inferiorly to below the cardiac apex.
A number of studies have compared 64DCT and
CAG on a segment-by-segment basis for the detec-
tion of coronary artery stenoses in the non-emergent
setting [11, 12, 43, 44]. Although 10–20% of
coronary artery segments cannot be assessed by
CTA because of motion artifacts or severe calcifica-
tions, the negative predictive value of this technique
is close to 100%, rendering CT a reliable method to
rule out coronary artery disease if the study can be
performed successfully. Unfortunately, the positive
predictive value is only around 75%, revealing a
tendency of CTA to overestimate the degree of
coronary artery stenoses. One of the reasons for
overestimation may be the presence of plaques which
appear to narrow the lumen, if adjacent widening of
the outer lumen (positive remodeling) is not taken
into account. Underestimation of the degree of
stenosis by CAG due to eccentric stenosis and
suboptimal angulation is presumably another cause.
The largest cohort reported so far with CCTA in the
ED comprised 103 patients with acute chest pain. By
using 50% coronary artery stenosis as detected by
MDCT as a threshold with clinical follow-up as the
reference standard, Hoffmann et al. reported a
positive and negative predictive value of 47% and
100% for ACS, respectively [26].
In a pilot study of 22 patients, Dorgelo et al.
reported on the potential use of MDCT to triage
patients with ACS among conservative treatment,
percutaneous intervention or bypass grafting [45].
They followed a simplified stratification scheme
taking the number of coronary vessels into account
affected by coronary artery disease with stenosis
50%. According to this scheme, the absence of
coronary artery disease, single- or two-vessel
disease, and left main or three-vessel disease
initiated conservative, interventional and surgical
therapy, respectively. They reported excellent agree-
ment for decisions made by MDCT and CAG for
triaging these patients with ACS. Interestingly, in
some patients MDCT more often showed the
tendency to triage for coronary intervention whereas
after cardiac catheterization these few patients were
treated conservatively. This presumably resulted
from lack of adequate clinical information such as
co-morbidity risk at MDCT that was available and
influenced the final decision after cardiac catheter-
ization [45].
Global Assessment (Triple Rule-Out)
The protocol for global assessment differs from
dedicated coronary CTA in several important re-
spects. First, a large field of view is used to
encompass the entire chest. Second, the entire length
of thorax must be imaged in order to assess the
pulmonary vasculature to a subsegmental level, as
well as the thoracic aorta. Such imaging requires a
longer acquisition of 15 s or more with 64-DCT with
more opportunity for motion artifact due to breathing.
It is therefore advisable to begin image acquisition
below the cardiac apex and scan superiorly, in
contrast to the cephalocaudal direction typically used
for dedicated CCTA. This approach permits imaging
of the coronary arteries during the first part of the
scan, when breath holding is presumably better.
A third important difference is the protocol for
contrast administration. Unlike dedicated coronary
CTA, where partial or complete washout of contrast
in the right heart is desirable, a triple rule-out
protocol must provide optimal enhancement of both
the right and left heart for simultaneous visualization
of the pulmonary arteries, the aorta and the coronary
arteries. Thus, a small amount of additional contrast
may be necessary and contrast bolus administration
may need to be lengthened.
Using the global assessment chest pain protocol,
White et al. investigated 69 patients with chest pain
in whom they assessed the amount of calcium, the
degree of stenosis, ejection fraction, wall motion
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abnormalities, and perfusion defects in the myocar-
dium [28]. The final diagnosis was derived from
clinical exam or follow up for 1 month. The CT was
normal, showed coronary artery disease, non-cardiac
related or non-concordant findings in 75, 14, 4, 7% of
patients, respectively. For the diagnosis of acute
coronary syndrome they reported a sensitivity and
specificity of 87 and 96%, respectively. In addition
White et al. reported findings in other areas such as
the lung, mediastinum and the bones. In this study
there were too few patients with aortic dissection or
pulmonary embolism to adequately establish the
diagnostic accuracy of this protocol for non-coronary
causes of acute chest pain.
Imaging evaluation and Post Processing
Within the context of an urgent clinical presentation,
the initial assessment of the CT scan must be rapid
and accurate for effective risk assessment of the
patient. In the broadest sense this means determining
if the patient is suffering from a life threatening
condition necessitating urgent therapy, such as an
acute coronary syndrome, an acute aortic syndrome,
or venous thromboembolism. This assessment rarely
requires visualization techniques beyond appropri-
ately windowed transverse reconstructions. Although
transverse sections represent the most basic output of
the CT scanner, attention must be focused on proper
assessment, as lesions can be missed or mischarac-
terized. In particular if the window center is too low
or narrow, an intimal flap within the aorta or a
pulmonary embolism can disappear within the con-
trast-enhanced lumen or a coronary occlusion asso-
ciated with calcific plaque could be mistaken for a
patent artery. As a general rule of thumb, proper
window width and center settings require that the
arterial lumen be not rendered as white, but an
intermediate gray level. Moreover, the size of mural
calcium will be overestimated (blooming) if it is not
rendered with an opacity level below white. As was
previously discussed, a thin-section acquisition, pref-
erably with overlapping reconstructions is critical to
fully assessing vascular abnormalities. With a tho-
racic CT angiogram comprising 400–4,000 transverse
reconstructions, it is impractical to effectively track
the structures of interest across multiple sheets of film
and spatial relationships will be difficult to ascertain.
If one of the aforementioned acute vascular
abnormalities is excluded based upon transverse
section review, then post processing will not be
necessary. While this should almost always be the
case when diagnosing an acute aortic syndrome or
pulmonary embolism, the confident exclusion of an
acute coronary syndrome may require a post-pro-
cessing workstation, particularly if there are motion-
related artifacts or calcified plaque.
A post-processing workstation is required if an
acute aortic or an acute coronary syndrome is
diagnosed or if an acute coronary syndrome cannot
be excluded. With an acute aortic syndrome, planning
of definitive therapy or triage to a period of moni-
toring necessitates characterization of the aortic
lumen, wall, branches, and adjacent structures. A
detailed description of the full scope of evaluations
necessary to fully characterize an acute aortic
syndrome is beyond the scope of this manuscript,
but the use of multiplanar reformations (MPRs),
curved planar reformations (CPRs), maximum inten-
sity projections (MIP), and volume renderings are
key to enabling complete characterization and doc-
umentation of the abnormality to facilitate commu-
nication with the treating physicians. Moreover, a
post-processing workstation is necessary to measure
important distances along axes and curved paths that
are aligned with aortic landmarks and not the CT
table, as is the case with the primary transverse
reconstructions.
When characterizing or excluding acute coronary
syndromes or acute aortic syndromes assessed with
ECG gated CT acquisitions, the post-processing
workstation must also be capable of managing
multiphasic or four-dimensional data to allow seam-
less volumetric exploration and analysis across the
temporal phases. While the tools of MPR, CPR, MIP
and volume rendering frequently are all necessary for
a complete assessment, the workstation must be
capable of managing up to 3–4,000 images simulta-
neously to allow seamless exploration of the 4-D
data. In the case of an acute coronary syndrome, the
primary goal of the analysis should be the identifi-
cation of the location and extent of the coronary
artery occlusion. While, as mentioned above, primary
transverse section review can allow exclusion of the
diagnosis, full characterization of the extent of the
abnormality, particularly in association with chronic
atherosclerotic coronary occlusive disease, requires
424 Int J Cardiovasc Imaging (2007) 23:415–427
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MPRs oriented perpendicular to median axis of the
artery and/or CPRs. Volume rendering can provide an
exquisite display of the relationships of the coronary
arteries relative to the myocardium, but this is rarely
necessary for urgent risk assessment.
When all phases are reconstructed across the
cardiac cycle, then MPRs oriented along the standard
cardiac axes can be viewed to assess for wall motion
abnormalities and perfusion deficits.
Physician requirements
In the United States there are competency guidelines
that provide minimum training requirements for
radiologists, cardiologists, and nuclear medicine
physicians for the interpretation of CTA [46, 47]. In
both Europe and Canada, government regulations
largely limit interpretation to radiologists. Like all of
imaging, there is a learning curve and some training
is desirable in order to achieve a measure of
competence. The extra-cardiac portion of the exam-
ination must be thoroughly evaluated as it has been
shown that there may be significant non-cardiac
abnormalities in the population of interest [48, 49].
Generally, this will require a radiologist over-read if
the radiologist is not the primary reader. The
American College of Radiology cautions against the
practice of split-reads, and legal consultation is
advisable in the U.S. [50].
Future directions
Ongoing research in CT technology suggests that the
evaluation of coronary arteries with MDCT will
improve substantially in the coming years. Software
improvements in post-processing will permit rapid
reconstruction of the coronary arteries with auto-
mated selection of the optimal cardiac phase. Hard-
ware improvements include better z-axis coverage
generating a larger number of slices as well as better
temporal resolution through the use of multiple tube
technology or faster gantry rotation. Such advances in
technology can be expected to improve the quality of
coronary artery imaging, particularly for the large
coverage required for the global assessment and will
undoubtedly stimulate further modifications in the CT
imaging protocols for ED patients with chest pain.
Summary
The major diagnostic concerns for acute chest pain
are acute myocardial infarction and acute coronary
syndrome. However, since enzyme blood levels may
be normal for many hours following an event, and
because ECG findings are often non-diagnostic,
2.8 million patients with acute chest pain in the
U.S. are admitted to hospital for evaluation and
management of chest pain. This patient subgroup has
a low risk for ACS yet undergo expensive investiga-
tions since the likelihood of bad outcome is
extremely high with a missed diagnosis.
In patients with chest pain whose history, clinical
findings and/or predisposing conditions suggest other
life threatening diseases, specifically acute aortic
syndromes or pulmonary embolism, MDCT is proven
to be the diagnostic study of choice [51, 52]. The CT
protocol used should be optimized to evaluate each of
these specific diagnoses, as completely as possible;
this implies that no single protocol is ideal for all
chest pain disease.
Regarding myocardial ischemia, numerous studies
have established that 16 and 64 slice MDCT has high
diagnostic accuracy for detecting significant coronary
artery stenosis in stable patients with a high preva-
lence of coronary artery disease. Furthermore,
preliminary studies indicate that MDCT can also
detect and characterize atherosclerotic plaque, and
these findings are in good agreement with intravas-
cular ultrasound (IVUS). It is therefore tempting to
believe that MDCT could identify patients with chest
pain of uncertain cause in the ED, many of whom
could then be safely discharged. Published pilot
studies in which MDCT was used to evaluate patients
in the ED for this purpose look promising, but have
only involved small patient numbers, and cannot be
regarded as definitive [26–28]. The Writing Group
feels that MDCT may provide novel and accurate
information on the presence of CAD, and can also
evaluate aortic dissection and pulmonary embolism.
However, large blinded clinical trials are needed to
determine the accuracy and precision of MDCT for
triage of patients with acute chest pain. Randomized
trials should be performed to evaluate the degree to
which MDCT enhances patient risk stratification, the
consequences of a universally standardized as
opposed to a targeted protocol, patient outcomes,
and cost-effectiveness compared with the current
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standard of care. Staffing issues also need to be
addressed since sufficient numbers of CT trained
physicians and technologists will be needed; ideally,
facilities should offer ECG gated MDCT service
24 h/day and 7 days per week.
Finally, the Writing Group was unanimous in its
belief that minimally invasive MDCT has indeed
considerable potential for improving the management
of selected patients with acute chest pain, and that the
necessary clinical research trials to clarify and estab-
lish its role in the ED should proceed with urgency.
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